Literature DB >> 656653

The sterilizing value of rifampicin and pyrazinamide in experimental short-course chemotherapy.

J Grosset.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 656653

Source DB:  PubMed          Journal:  Bull Int Union Tuberc        ISSN： 0074-9249


× No keyword cloud information.
  28 in total

1.  Tuberculosis control: challenges of an ancient and ongoing epidemic.

Authors:  Kristin J Cummings
Journal:  Public Health Rep       Date:  2007 Sep-Oct       Impact factor: 2.792

2.  Testing of experimental compounds in a relapse model of tuberculosis using granulocyte-macrophage colony-stimulating factor gene-disrupted mice.

Authors:  Lisa K Woolhiser; Donald R Hoff; Karen S Marietta; Ian M Orme; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2008-10-13       Impact factor: 5.191

Review 3.  Dormancy of Mycobacterium tuberculosis and latency of disease.

Authors:  L G Wayne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

4.  Pyrazinoic acid decreases the proton motive force, respiratory ATP synthesis activity, and cellular ATP levels.

Authors:  Ping Lu; Anna C Haagsma; Hoang Pham; Janneke J Maaskant; Selena Mol; Holger Lill; Dirk Bald
Journal:  Antimicrob Agents Chemother       Date:  2011-08-29       Impact factor: 5.191

5.  Synergistic Activity of Clofazimine and Clarithromycin in an Aerosol Mouse Model of Mycobacterium avium Infection.

Authors:  Jean-Philippe Lanoix; Cédric Joseph; François Peltier; Sandrine Castelain; Claire Andréjak
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

6.  Consequences of noncompliance for therapy efficacy and emergence of resistance in murine tuberculosis caused by the Beijing genotype of Mycobacterium tuberculosis.

Authors:  Jurriaan E M de Steenwinkel; Marian T ten Kate; Gerjo J de Knegt; Henri A Verbrugh; Rob E Aarnoutse; Martin J Boeree; Michael A den Bakker; Dick van Soolingen; Irma A J M Bakker-Woudenberg
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

7.  Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice.

Authors:  Herve Dega; Abdelhalim Bentoucha; Jerome Robert; Vincent Jarlier; Jacques Grosset
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

8.  Evaluation of moxifloxacin-containing regimens in pathologically distinct murine tuberculosis models.

Authors:  Si-Yang Li; Scott M Irwin; Paul J Converse; Khisi E Mdluli; Anne J Lenaerts; Eric L Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

9.  Isoniazid protects mice against endotoxin lethality without influencing tumor necrosis factor synthesis and release.

Authors:  R Urbaschek; D N Männel; R Urbanczik
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

10.  Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis.

Authors:  Deepak Almeida; Eric Nuermberger; Rokeya Tasneen; Ian Rosenthal; Sandeep Tyagi; Kathy Williams; Charles Peloquin; Jacques Grosset
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.